Traveler’s Diarrhea Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Traveler’s diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of feces (one or more by some definitions and three or more by others) that are not formed during travel. It may be accompanied by abdominal cramps, nausea, fever and bloating. Sometimes bloody diarrhea can occur. Most travelers recover within 4 days with little or no treatment.

Traveler’s Diarrhea Therapeutics market size is projected to reach US$ 1265.9 million by 2027, from US$ 838.8 million in 2020, at a CAGR of 7% during 2021-2027.

This report includes the following manufacturers:

• Salix Pharmaceuticals
• P&G
• Johnson & Johnson
• Otsuka Pharma
• Valneva
• Shanghai United Cell

Market Segment by Application

• Adult Traveler’s Diarrhea
• Children Traveler’s Diarrhea

Scope of the Report

The research study analyzes the global Traveler’s Diarrhea Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Traveler’s Diarrhea Therapeutics Market Report

1. What was the Traveler’s Diarrhea Therapeutics Market size in 2019 and 2021; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of Traveler’s Diarrhea Therapeutics Market during the forecast period (2021-2027)?

3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).

4. Which manufacturer/vendor/players in the Traveler’s Diarrhea Therapeutics Market was the market leader in 2021?

5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.